Radionuclide Treatments

Radionuclide treatments are on the rise. Until few years ago, the use of radioisotopes in therapy was limited predominantly to treatment of hyperthyroidism, thyroid cancer, polycythemia rubra vera, bone metastases (palliative), liver tumor/ metastases, neuroblastoma, pheochromocytoma and paragangliomas. In recent years Lu-177 and Y-90 labeled somatostatin analogs, Lu-177 labeled PSMA ligands, and Ra-223 dichloride treatments have been increasingly used. In this section, current common radionuclide treatment protocols will be summarized for practical use. Various case studies before and after radionuclide treatments will be presented.